BunyaVax will present at the Animal Health Investment Summit in Londen that will take place on 20-21 Februari 2018. BunyaVax is one of the 12 finalists that have been selected to present.
Animal Health Investment Europe is dedicated to showcasing to investors the most innovative emerging animal health companies covering the companion, aquaculture and production animal space. During the Innovation Showcase emerging and pre-revenue organisations will pitch their company in front of a room of investors.
Over 35 start-up animal health companies were nominated, out of which 12 companies were selected. BunyaVax is one of the 12 finalists.
According to the organization: “Each start-up was chosen for their breakthrough innovations and the new opportunities they present across the industry, including: nutritional health, vaccines, microbiome drug discovery, data analytics and pharmaceuticals.”
About BunyaVax: BunyaVax is the first company to develop Plug & Play vaccine technology that generates inherently safe and efficacious vaccines within a timeframe of weeks. Especially during outbreaks of new and life-threatening virus strains, rapid and affordable vaccination is essential. The Plug & Play feature allows for introduction of any desired gene into the RNA particle genome. Vaccination with BunyVax RNA particles was shown to induce durable protection against highly pathogenic viruses in both laboratory animals and target animals.